Status:

COMPLETED

Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Conditions:

Ovarian Carcinoma

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

The main purpose of this study is to determine the safety and tolerability of giving both paclitaxel and carboplatin in the abdominal cavity by looking at what effects (good and bad) this route of adm...

Detailed Description

Patients will have an intraperitoneal port placed at the time of their initial surgery or at a second procedure prior to cycle 2 of chemotherapy. Patients will receive a total of 6 cycles of therapy ...

Eligibility Criteria

Inclusion

  • Histologically confirmed epithelial carcinoma of mullerian origin. Specifically, ovarian, primary peritoneal and tubal carcinoma
  • Stage II or III disease
  • Patient must have undergone surgical staging and debulking with optimal cytoreduction
  • Able and willing to undergo a second look staging laparotomy
  • 18 years of age or older
  • Adequate bone marrow function with an Absolute Neutrophil Count (ANC) \> 2,500 and platelets \> 100,000/mm3
  • ECOG performance status less than or equal to 2

Exclusion

  • Disease outside the abdominal cavity
  • Stage IV disease, including abdominal wall, visceral and/or pleural involvement
  • Previous chemotherapy for ovarian cancer
  • Suboptimal cytoreduction
  • Creatinine \> 1.5 mg/dl
  • History of recent Myocardial Infarction or congestive heart failure within 6 months of surgery
  • SGOT \> 2x Upper Limit of Normal (ULN), bilirubin \> 1.5 x ULN
  • Colostomy or ileostomy
  • Concurrent invasive malignancy
  • Known hypersensitivity to E. coli derived products
  • Active psychiatric or mental illness precluding informed consent

Key Trial Info

Start Date :

October 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2006

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT00181701

Start Date

October 1 2004

End Date

May 1 2006

Last Update

April 14 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.